Physician

John Martin Prince, MD

According to 2025 Medicare claims, John Prince, MD (NPI: 1861501991) practices pulmonary disease in the Knoxville, TN market, with the plurality of this provider's patient population coming from Knox, TN. This provider's primary affiliated billing organization is STATCARE OUTPATIENT, LLC (NPI: 1134653892; TIN: 814704105) and primary practice location at 37934-2952.

Prince's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 354 traditional Medicare patients, billed 36,766 HCPCS/CPT codes, and received $811,409 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,345 prescription claims across 309 beneficiaries totaling $753,568 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 313 claims. Open Payments data shows 130 records totaling $19,766. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $113,000 to $811,409. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $536,877 and ending at $753,568. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $45,744 and ending at $26,727.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	363	1,424	$113,000
2016	440	2,315	$143,738
2017	461	2,236	$127,924
2018	423	2,805	$100,702
2019	400	2,635	$93,017
2020	393	1,898	$118,223
2021	348	2,377	$160,001
2022	307	2,077	$113,619
2023	347	10,638	$334,363
2024	354	36,766	$811,409

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	117	787	$536,877
2016	138	674	$368,727
2017	143	912	$285,527
2018	160	742	$316,537
2019	164	764	$390,830
2020	150	704	$517,944
2021	149	683	$481,334
2022	155	652	$316,719
2023	197	844	$530,227
2024	309	1,345	$753,568

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	56	503	$25,927
2016	52	537	$35,240
2017	34	374	$20,127
2018	17	271	$16,778
2019	23	402	$27,023
2020	15	345	$39,601
2021	N/R	177	$14,466
2022	N/R	161	$17,835
2023	N/R	239	$12,517
2024	49	313	$18,470

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	204	347	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	147	184	$55
94729	Test to examine how well the lungs exchange gases	152	163	$37
94010	Test to measure expiratory airflow and volume	172	195	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	149	227	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	287	11,610	$240,475
Ofev	Nintedanib Esylate	11	330	$142,861
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	151	5,760	$119,685
Breo Ellipta	Fluticasone/Vilanterol	118	4,616	$57,797
Symbicort	Budesonide/Formoterol Fumarate	86	3,810	$26,470

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	28	152	$13,450
E1392	Portable oxygen concentrator, rental	Y	21	119	$4,291
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	17	$391
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	11	$285
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	14	$53

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	130	$19,766	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Martin Prince, MD?

Tedicare shows public-source Medicare data for John Martin Prince, MD (NPI 1861501991), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Martin Prince, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Martin Prince, MD?

John Martin Prince, MD is linked to STATCARE OUTPATIENT, LLC (billing NPI 1134653892) in the available physician profile data.

Does John Martin Prince, MD have Open Payments data?

John Martin Prince, MD has 130 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.